Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: A prospective clinical study

Coronary Artery Disease

Volumn 22, Issue 3, 2011, Pages 179-187

  Mazzone, Annamaria ^a,d   Parri, Maria Serena ^a   Giannessi, Daniela ^b   Ravani, Marcello ^a   Vaghetti, Marco ^a   Altieri, Paola ^c   Casalino, Laura ^c   Maltinti, Maristella ^b   Balbi, Manrico ^c   Barsotti, Antonio ^c   Berti, Sergio ^a  

^a Fondazione G Monasterio CNR Regione Toscana   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d G Monasterio Foundation   (Italy)

Author keywords

Accelerated atherosclerosis; coronary artery disease inflammation; instent restenosis; osteopontin

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; OSTEOPONTIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC PATIENT; CHRONIC CORONARY SYNDROME; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OSTEOPONTIN; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES;

EID: 79955058931     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283441d0b     Document Type: Article

References (30)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Shoenfeld Y, Gerli R, Doria M, Matsuura E, Cerinic MM, Ronda N, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005; 112:3377-3334.
3. Libby P. Act local, act global: inflammation and multiplicity of 'vulnerable' coronary plaques. J Am Coll Cardiol 2005; 45:1600-1602. (Pubitemid 40704492)
4. Gaspardone A, Versaci F. Coronary stenting and inflammation. Am J Cardiol 2005; 96:65L-70L.
5. Kanter JE, Averill MM, Leboeuf RC, Bornefeldt KE. Diabetes-accelerated atherosclerosis and inflammation. Circ Res 2008; 103:e116-e117.
6. Spagnoli LG, Bonanno E, Mauriello A, Calmieri G, Partenzi A, Sangiorgi G, et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002; 40: 1579-1588. (Pubitemid 35253635)
7. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5-12. (Pubitemid 34728951)
8. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004; 110:1747-1753. (Pubitemid 39299216)
9. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Aldama J, Pizzi C, Quiles J, et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 2004; 90:847-852. (Pubitemid 39022574)
10. Bauriedel G, Skowasch D, Vaerst J, Jabs A, Andrie R, Luderitz B. Association between progression of untreated coronary lesions and in-stent restenosis. Dtsch Med Wochenschr 2002; 127:2114-2119. (Pubitemid 35216703)
11. Glaser R, Selzer F, Faxon DP, Laskey WK, Holper EM, Cohen HA, et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 2005; 111:143-149. (Pubitemid 40139724)
12. Gravallese EM. Osteopontin: a bridge between bone and the immune system. J Clin Invest 2003; 112:147-149. (Pubitemid 38056349)
13. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 1994; 14:1648-1656.
14. Golledge J, McCann M, Mangan S, Lam A, Karam M. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 2004; 35:1636-1641. (Pubitemid 38823639)
15. Ohmori R, Momiyamaa Y, Taniguchi H, Takahashi R, Kusuraka M, Ohsuzu F. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003; 170:333-337. (Pubitemid 37377807)
16. Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, et al. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J 2006; 27:802-807.
17. Bertrand ME, Simoons ML, Fox KA,Wallentin LC, Hamm CW, McFadden E, et al. Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002; 23:1809-1840. (Pubitemid 35398051)
18. +T cells in patients with unstable angina. Circ J 2006; 70:851-856. (Pubitemid 43979121)
19. Coskun S, Atalar E, Ozturk E, Yavuz B, Ozer N, Goker H, et al. Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes. J Natl Med Assoc 2006; 98:1746-1750. (Pubitemid 44885528)
20. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27:2302-2309. (Pubitemid 350203943)
21. Liuzzo G, Vallejo AN, Kopecky SL, Frye RL, Holmes DR, Goronzy JJ, et al. Molecular fingerprint of interferon-gamma signaling in unstable angina. Circulation 2001; 103:1509-1514. (Pubitemid 32226257)
22. Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Rebuzzi AG, Crea F, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34:1512-1521. (Pubitemid 29528666)
23. Segev A, Kassam S, Buller CE, Lau HK, Sparkes ID, Connelly PPW, et al. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predictate coronary angiographic restenosis after elective stenting. Eur Heart J 2004; 25:1029-1035. (Pubitemid 38869421)
24. Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schächinger V, Zeiher AM, et al. C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001; 37:839-846. (Pubitemid 32202453)
25. Zairis MN, Psaltiras GP, Papadaki OA, Psarogianni PK, Lyras AG, Giannakopoulos AK, et al. C-reactive protein and multiple complex coronaryartery plaques in patients with primary unstable angina. Atherosclerosis 2002; 164:355-359. (Pubitemid 35223087)
26. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, De Blois D, Giachelli CM. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol 1997; 17:188-193. (Pubitemid 27057342)
27. Panda D, Kundu GC, Lee BI, Peri A, Yuan CJ, Mukherejee AB. Potential roles of osteopontin and alfavbeta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A 1997; 94:9308-9313.
28. Kato R, Momiyama Y, Ohmori R, Tanaka N, Taniguchi H, Arakawa K, et al. High plasma levels of osteopontin in patients with restenosis after percutaneous coronary intervention. Arterioscl Thromb Vasc Biol 2006; 26:1-2.
29. Kato R, Momiyama Y, Ohmori R, Tanaka N, Taniguchi H, Arakawa K, et al. Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention. Circ J 2009; 73:152.
30. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Rebuzzi AG, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98:2370-2376. (Pubitemid 28549779)